The Yale Secret Shopper Study, Full Breakdown: 45 of 49 Sites Failed the Basics
This is the study that defines our mission. A JAMA-published secret shopper investigation sent researchers posing as patients to 49 telehealth GLP-1 platforms in early July 2026. Here's the full breakdown.
What researchers actually did
Trained researchers submitted standardized patient profiles to each platform, then evaluated the rigor of clinical review before a prescription was approved — specifically whether a licensed clinician engaged with the specific answers submitted, or whether approval happened largely automatically.
What separated the 4 that passed
What the successful platforms had in common
- Documented, individualized clinician review before approval
- Follow-up questions triggered by specific intake answers, not a uniform process regardless of input
- A defined monitoring plan beyond the initial prescription
Sesame Care From $29
A licensed physician network with documented individualized review.
Embody GLP1 From consult
Injectable semaglutide with documented clinical review as part of standard process.
Visit Embody GLP1 →Paid linkWhat to do with this information
Use our verification tool before committing to any provider, and ask directly whether a clinician will individually review your specific intake — not just whether "licensed clinicians" are involved somewhere in the process.